Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamide

被引：32

作者：

Hamaguchi, T ^{[1
]}

Hirose, T ^{[1
]}

Asakawa, H ^{[1
]}

Itoh, Y ^{[1
]}

Kamado, K ^{[1
]}

Tokunaga, K ^{[1
]}

Tomita, K ^{[1
]}

Masuda, H ^{[1
]}

Watanabe, N ^{[1
]}

Namba, M ^{[1
]}

机构：

[1] Hyogo Med Univ, Dept Internal Med, Div Diabet & Metab, Nishinomiya, Hyogo 6638501, Japan

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2004年 / 66卷

关键词：

third-generation sulfonylurea; extrapancreatic effects; insulin resistance; metabolic syndrome;

D O I：

10.1016/j.diabres.2003.12.012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Multicentric study was conducted to evaluate the efficacy of glimepiride in the oral hypoglycemic agents therapy of type 2 diabetic patients treated with glibenclamide so far, and to claim an adequate use of this new generation sulfonylurea. In 66 diabetic outpatients, glibenclamide was switched to glimepiride. After 6 months' therapy, a significant reduction in fasting plasma IRI was observed in relatively hyperinsulinemic patients. In addition, weight reduction was achieved in patients with insulin resistance during this study. These findings suggest that glimepiride improves insulin resistance in hyperinsulinemic patients treated with glibenclamide. Also, glimepiride is favored especially for overweight, insulin-resistant patients inadequately controlled by glibenclamide. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

引用

页码：S129 / S132

页数：4

共 50 条

[41] Evaluation of the efficacy of repaglinide compared with glibenclamide in newly diagnosed type 2 diabetic patients by continuous glucose monitoring system
Lu, JM
Wang, XL
Pan, CY
Zhai, HW
DIABETOLOGIA, 2005, 48 : A284 - A284
[42] Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl(R)): A double-blind comparison with glibenclamide
Draeger, KE
WernickePanten, K
Lomp, HJ
Schuler, E
Rosskamp, R
HORMONE AND METABOLIC RESEARCH, 1996, 28 (09) : 419 - 425
[43] Efficacy and safety of treatment with simvastatin in thiazolidinedione-treated Type 2 diabetic patients
Kipnes, MS
Lewin, AJ
Meneghini, LF
Perevozskaya, I
Shah, S
Plotkin, D
Tobert, J
DIABETOLOGIA, 2002, 45 : A388 - A388
[44] Comparative effects of metformin and glibenclamide on the redox balance in type 2 diabetic patients
Almulathanon, Ammar A. Y.
Mohammad, Jehan A.
Fathi, Fatimah Haitham
PHARMACIA, 2021, 68 (02) : 327 - 332
[45] Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients
Fischer, S
Patzak, A
Rietzsch, H
Schwanebeck, U
Köhler, C
Wildbrett, J
Fuecker, K
Temelkova-Kurktschiev, T
Hanefeld, M
DIABETES OBESITY & METABOLISM, 2003, 5 (01): : 38 - 44
[46] Effects of glibenclamide and metformin on prevalence of metabolic syndrome in type 2 diabetic patients
Mahmood, Isam Hamo
Nazar, Weijdan
PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2011, 27 (05) : 1033 - 1037
[47] Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats
El-Reyani, NE
Bozdogan, Ö
Baczkó, I
Leprán, I
Papp, JG
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 365 (2-3) : 187 - 192
[48] Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients
Nagayama, D.
Saiki, A.
Endo, K.
Yamaguchi, T.
Ban, N.
Kawana, H.
Ohira, M.
Oyama, T.
Miyashita, Y.
Shirai, K.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (13) : 1796 - 1801
[49] Improved glycaemic control by addition of glimepiride to metformin monotherapy in Type 2 diabetic patients
Charpentier, G
Fleury, F
Kabir, M
Vaur, L
Halimi, S
DIABETIC MEDICINE, 2001, 18 (10) : 828 - 834
[50] KINETICS AND EFFICACY OF GLIMEPIRIDE IN DIABETIC-PATIENTS WITH KIDNEY-DISEASE
ROSENKRANZ, B
MALERCZYK, V
LEHR, KH
RINGOIR, S
LAMEIRE, NH
METELKO, Z
PROFOZIC, V
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 207 - 207

← 1 2 3 4 5 →